Jonathan T. Lord M.D., Director at DEXCOM INC (DXCM), bought 39,819 shares at $10.72 ($429K) on 2010-05-14, disclosed to the SEC on 2010-05-18.
Open-market purchase of $429k DXCM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.69 | 300 | $3K | 0.7% |
| 2 | $10.70 | 1,300 | $14K | 3.2% |
| 3 | $10.72 | 100 | $1K | 0.2% |
| 4 | $10.73 | 4,000 | $43K | 10.0% |
| 5 | $10.74 | 300 | $3K | 0.8% |
| 6 | $10.74 | 400 |
| $4K |
| 1.0% |
| 7 | $10.75 | 12,920 | $139K | 32.3% |
| 8 | $10.75 | 100 | $1K | 0.3% |
| 9 | $10.75 | 200 | $2K | 0.5% |
| 10 | $10.76 | 100 | $1K | 0.3% |
| 11 | $10.77 | 100 | $1K | 0.3% |
| 12 | $10.78 | 700 | $8K | 1.8% |
| 13 | $10.79 | 100 | $1K | 0.3% |
| 14 | $10.80 | 9,002 | $97K | 22.6% |
| 15 | $10.84 | 300 | $3K | 0.8% |
| 16 | $10.85 | 9,897 | $107K | 25.0% |
| Total | $10.78 avg | 39,819 | $429K | 100% |
| Filing → |
| BIOL | BUY | 2018-11-20 | $14K | — | Filing → |
| BIOL | BUY | 2018-08-14 | $218K | — | Filing → |
| DXCM | SELL | 2016-09-06 | $915K | — | Filing → |